Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
havasu78's Profile
Displaying 351-400 of 491 result(s).
CYDY CytoDyn Inc
09/30/2020 8:11:15 PM
Totally agree with your perspective (1)
CYDY CytoDyn Inc
09/30/2020 7:01:19 PM
Thanks TechGuru. I agree 56% mortal
CYDY CytoDyn Inc
09/30/2020 6:56:54 PM
32 deaths in placebo and 8 in leron (1)
CYDY CytoDyn Inc
09/30/2020 4:44:05 PM
i would say LL knocks it out of the (1)
CYDY CytoDyn Inc
09/30/2020 4:37:40 PM
FORTY-FIVE deaths in CD12 is a mass (1)
CYDY CytoDyn Inc
09/30/2020 4:35:26 PM
TechGuru, did you see the slide tod (4)
CYDY CytoDyn Inc
09/29/2020 10:39:25 PM
I think those numbers are wrong. If
RLFTF Mondobiotech Holding AG Basel
09/22/2020 9:50:12 PM
Javitt transcript seems to suggest
CYDY CytoDyn Inc
09/19/2020 1:52:22 PM
Data collection for CD12 severe/cri (5)
CYDY CytoDyn Inc
09/17/2020 12:15:59 AM
Maybe you are right. Maybe he is ly (8)
CYDY CytoDyn Inc
09/17/2020 12:00:43 AM
Sure Patterson can do a 4 millilite
CYDY CytoDyn Inc
09/16/2020 9:04:09 PM
Nope, its not radioactive isotopes.
CYDY CytoDyn Inc
09/16/2020 8:49:14 PM
For example, Pourhassan did the rig (3)
CYDY CytoDyn Inc
09/16/2020 8:45:11 PM
Today's conference call was bad bec (7)
CYDY CytoDyn Inc
09/16/2020 8:28:03 PM
ohm, do you have any references for (1)
CYDY CytoDyn Inc
09/14/2020 9:13:02 PM
I do not think Multiple Sclerosis p (1)
CYDY CytoDyn Inc
09/14/2020 5:54:01 PM
CD12 p value. Thanks tech, ohm, bor (5)
CYDY CytoDyn Inc
09/13/2020 11:29:15 PM
27% mortality in the placebo arm wo
CYDY CytoDyn Inc
09/13/2020 11:22:16 PM
the major feature of the remdesivir (2)
CYDY CytoDyn Inc
09/13/2020 2:45:18 PM
i think this board is great, too. b (2)
CYDY CytoDyn Inc
09/12/2020 10:38:06 PM
CD12 statistics: p=0.5 with 12 deat (1)
CYDY CytoDyn Inc
09/12/2020 8:57:05 PM
Thanks, CT, there's one there I hav
CYDY CytoDyn Inc
09/12/2020 6:57:32 PM
Thanks for your reply, ohm. Yres, s (2)
CYDY CytoDyn Inc
09/12/2020 5:28:38 PM
MD, I think you are mischaracterizi (1)
CYDY CytoDyn Inc
09/12/2020 5:07:33 PM
Is it easy to cure EAE in mice? May (4)
CYDY CytoDyn Inc
09/12/2020 4:35:05 PM
MD, the link you posted explains wi (4)
CYDY CytoDyn Inc
09/12/2020 4:26:49 PM
IMMU's Trodelvy has already complet (1)
CYDY CytoDyn Inc
09/11/2020 10:38:14 PM
very persuasive FBcoach but I think (3)
CYDY CytoDyn Inc
09/09/2020 6:54:32 PM
I agree, CT, tech pubs that cytokin
CYDY CytoDyn Inc
09/08/2020 8:26:06 PM
I doubt its unexpected. Quick googl (1)
CYDY CytoDyn Inc
09/08/2020 5:58:13 PM
Yesterday, someone posted a link to
CYDY CytoDyn Inc
09/08/2020 4:05:34 PM
OK, I get it now. your guess is tha
CYDY CytoDyn Inc
09/08/2020 3:32:22 PM
UK MHRA "Path to market" could be c
CYDY CytoDyn Inc
09/08/2020 3:29:16 PM
I don't understand what you are say
CYDY CytoDyn Inc
09/07/2020 11:38:31 PM
Is there a Parkinson's thread on th (1)
CYDY CytoDyn Inc
09/07/2020 11:29:16 PM
Indeed if UK approves and CYDY has (2)
CYDY CytoDyn Inc
09/07/2020 10:18:24 PM
Maybe "path to market" means no UK (1)
CYDY CytoDyn Inc
09/07/2020 3:24:57 PM
That's a good explanation, Cdiddy. (2)
CYDY CytoDyn Inc
09/07/2020 3:01:49 PM
A one hour meeting is just ridiculo (1)
CYDY CytoDyn Inc
09/07/2020 12:02:22 AM
Well, that post makes me feel bette (3)
CYDY CytoDyn Inc
09/06/2020 11:51:18 PM
I pretty much totally agree with yo (4)
CYDY CytoDyn Inc
09/06/2020 11:32:04 PM
I did not know that the FDA tuesday (1)
CYDY CytoDyn Inc
09/06/2020 8:21:03 PM
Its 28 days, not 14. The primary en
CYDY CytoDyn Inc
09/06/2020 6:47:46 PM
I don't see Pourhassan as trying to (8)
CYDY CytoDyn Inc
09/06/2020 6:28:06 PM
FDA said no HIV Type A meeting. The (1)
CYDY CytoDyn Inc
09/03/2020 10:54:07 PM
Re: Ohm's list of LL indications: C
CYDY CytoDyn Inc
09/03/2020 12:30:18 AM
What does MMHRA Fast Track mean? On
CYDY CytoDyn Inc
08/23/2020 5:36:10 PM
Hmmm...Landstreet is a contributor
CYDY CytoDyn Inc
08/23/2020 5:04:12 PM
The Forbes article wasn't written b
CYDY CytoDyn Inc
08/21/2020 11:42:57 PM
10blade posted: I'm having difficul
Go to page:
  • << First
  • < Previous
  • 7
  • 8
  • Next >

Recent Articles

  • DMG Blockchain Solutions Reveals Impressive September Results
  • Nvidia's Bold $2 Billion Investment in xAI and Future Plans
  • Cryptocurrency Market Retreats While Gold Sees New Heights
  • Trade Talks Set to Evolve Between U.S. and Canada Leaders
  • Important Update for Investors Affected by Snap Class Action
  • Fluor Corporation Lawsuit: Key Information for Investors
  • Investor Advisory: Lead Plaintiff Deadline Approaching for Dow Inc.
  • Investor Alert: Important Updates on V.F. Corporation Class Action
  • Cytokinetics Investors Reminded of Class Action Deadline
  • Investors Encouraged to Join Class Action Against KBR, Inc.
  • Top Stocks to Watch: Insights on POET Technologies and More
  • Esperion Therapeutics Unveils New Common Stock Offering
  • Matachewan Consolidated Mines Updates on Recent Share Sales
  • Faraday Future Expands Leadership with Industry Experts for Growth
  • KinderCare Investors Urged to Act Ahead of Class Action Deadline
  • Key Updates on C3.ai Investors Rights in Recent Lawsuit
  • Hope Medicine Inc. Celebrates Milestone in Endometriosis Treatment
  • VIVOTEK's 25th Anniversary: Shaping the Future of Security
  • Faraday Future Expands Leadership with New Industry Experts
  • Innovative Partnership to Enhance Leadership Development Globally
  • Fluor Corporation Investors: Important Lawsuit Update Ahead
  • Korea Creative Content Agency Launches U-KNOCK 2025 Event
  • Edelson Lechtzin LLP Steps in After AppFolio Data Breach
  • Excitement Grows with Aristocrat's New MONOPOLY Game Launch
  • Exciting New Season of Healthy Eating Series Premieres Soon
  • CARsgen's Breakthrough GPRC5D CAR-T Therapy Emerges in Research
  • Eloro Resources Acquires Substantial Stake in Cartier Silver Corp
  • Dr. Talal Debs to Propose New Leadership for Zefiro Methane
  • Unlocking the Potential of Gilead Sciences: Stock Journey
  • Iris Indie Hosts Groundbreaking Global Premiere Event
  • Celebrating Innovation: Young Scientists Awarded for Breakthroughs
  • Inspiring Achievements: Frank Leibfarth's Impactful Chemistry
  • Honoring Educational Innovators: SchoolsFirst's Commitment
  • KOCCA's U-KNOCK 2025: A New Era for Global Content
  • Gray Capital Expands Portfolio with New Multifamily Investment
  • How a $1000 Investment in Popular Stock Could Grow Today
  • A $1,000 Investment in CACI International: A 5-Year Journey
  • SelectQuote (SLQT) Faces Ethical Dilemmas Amid Legal Challenges
  • KBR, Inc. Faces Legal Challenges Following Major Contract Loss
  • Globalink Expands Deadline for Business Combination to 2025
  • Exploring McEwen Copper's Ambitious Sustainable Copper Project
  • Koryx Copper Updates on Shareholder Meeting Changes
  • Investing in Howmet Aerospace: A 5-Year Review of Growth
  • Cartier Silver Secures $1.2M Financing for Growth Initiatives
  • Can Opendoor Emulate Tesla's Remarkable Growth Strategy?
  • Gray Capital Expands Portfolio with $25M Acquisition in Indiana
  • Rodeo Dental Celebrates Milestone with a Community Festival
  • NACG Secures Additional $125 Million through Note Offering
  • Cartier Silver Completes Successful Financing Round for Growth
  • North American Construction Group Ltd. Boosts Unsecured Notes
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site